(Q66402287)
Statements
Phase 1 Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Soft Tissue Sarcoma and Renal Cell Carcinoma (English)
0 references
8 July 2016
0 references
24 November 2016
0 references
6
0 references
18 year
0 references